Tarun Sisodia - Head-Instl Research at Anand Rathi Financial Services told CNBC-TV18, "We are bullish on midcap pharma as well as the midcap IT sector. We have been pushing Suven Life Sciences to our clients a lot for over the last six months to 12 months. We continue to remain bullish on some of these stocks that we cover. In the conference we have had number of companies which we don’t cover as of now but we will soon be covering. As of now amongst these stocks that we cover Suven would be our top pick."On Wednesday, Suven Life Sciences closed at Rs 249.15, up Rs 0.05, or 0.02 percent. It has touched an intraday high of Rs 255.90 and an intraday low of Rs 245.70.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!